drugset / Trial / NCT00109551

Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal

NCT00109551 ↗

RandomizedFactorialDouble-blindPrevention

Summary

The purpose of this study is to determine whether daily supplementation of young children in Nepal with either zinc, iron-folic acid, or both can reduce mortality and morbidity. Young children in Nepal have numerous nutritional deficiencies and high rates of morbidity and mortality. Zinc and/or iron supplementation may be a cost-effective method for reducing these risks.

Timeline

Start
2001-10
Primary completion
—
Completion
2006-01

Outcome

Missed primary endpoint

paper There was no significant difference in mortality between the zinc and placebo groups (316 vs 333 deaths; hazard ratio 0.92, 95% CI 0.75-1.12). PMID 17920918 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron Sulfate Small molecule 6.25 mg Oral
Subject Iron Sulfate Small molecule 12.5 mg Oral
Subject Zinc Sulfate Unknown 5 mg Oral
Subject Zinc Sulfate Unknown 10 mg Oral
Subject folic acid Other / unclassified 25 ug Oral
Subject folic acid Other / unclassified 50 ug Oral

Indications

No indication recorded.